https://www.ajmc.com/view/taletrectinib-recommended-in-nccn-guidelines-for-ros1-positive-nsclc
Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line...
taletrectinibrecommendednccnguidelinespositive